We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer, Allergan Call off Merger Over New Treasury Rules
Pfizer, Allergan Call off Merger Over New Treasury Rules
It took Pfizer and Allergan less than 48 hours to nix their plan to build one of the world’s largest drugmakers, placing the blame squarely on the U.S. Treasury Department.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor